Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells

Jiyeon Ham, Whasun Lim, Fuller W. Bazer, Gwonhwa Song

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Silibinin is a flavonolignan extracted from seeds of milk thistles. Traditionally, it has been used as a therapeutic agent for liver disorders, and now it is well-known for its anti-cancer effects. However, studies on anti-cancer effects of silibinin on choriocarcinoma are very limited. Therefore, we performed proliferation and apoptosis assays to determine effects of silibinin on the viability of human choriocarcinoma (JAR and JEG3) cells. Our results showed that silibinin significantly inhibited proliferation and induced apoptosis in both JAR and JEG3 cells, and significantly increased reactive oxygen species (ROS) and lipid peroxidation. Moreover, silibinin disrupted mitochondrial function by inducing permeabilization of mitochondrial membrane potential and calcium ion efflux in JAR and JEG3 cells. Furthermore, silibinin-induced apoptosis in choriocarcinoma cells via AKT, mitogen-activated protein kinases (MAPK) and unfolded protein response (UPR) signal transduction. Collectively, our results suggest that silibinin is a novel therapeutic agent or dietary supplement for management of human placental choriocarcinomas.

Original languageEnglish
Pages (from-to)1638-1649
Number of pages12
JournalJournal of Cellular Physiology
Volume233
Issue number2
DOIs
Publication statusPublished - 2018 Feb 1

Fingerprint

Choriocarcinoma
Reactive Oxygen Species
Apoptosis
Flavonolignans
Dietary supplements
Unfolded Protein Response
Protein Unfolding
Signal transduction
Mitochondrial Membrane Potential
Dietary Supplements
silybin
Mitogen-Activated Protein Kinases
Liver
Lipid Peroxidation
Seed
Assays
Signal Transduction
Neoplasms
Seeds
Milk

Keywords

  • apoptosis
  • choriocarcinoma
  • ER stress
  • ROS
  • silibinin

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells. / Ham, Jiyeon; Lim, Whasun; Bazer, Fuller W.; Song, Gwonhwa.

In: Journal of Cellular Physiology, Vol. 233, No. 2, 01.02.2018, p. 1638-1649.

Research output: Contribution to journalArticle

@article{70d52c91a291442e89aaef3311a37747,
title = "Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells",
abstract = "Silibinin is a flavonolignan extracted from seeds of milk thistles. Traditionally, it has been used as a therapeutic agent for liver disorders, and now it is well-known for its anti-cancer effects. However, studies on anti-cancer effects of silibinin on choriocarcinoma are very limited. Therefore, we performed proliferation and apoptosis assays to determine effects of silibinin on the viability of human choriocarcinoma (JAR and JEG3) cells. Our results showed that silibinin significantly inhibited proliferation and induced apoptosis in both JAR and JEG3 cells, and significantly increased reactive oxygen species (ROS) and lipid peroxidation. Moreover, silibinin disrupted mitochondrial function by inducing permeabilization of mitochondrial membrane potential and calcium ion efflux in JAR and JEG3 cells. Furthermore, silibinin-induced apoptosis in choriocarcinoma cells via AKT, mitogen-activated protein kinases (MAPK) and unfolded protein response (UPR) signal transduction. Collectively, our results suggest that silibinin is a novel therapeutic agent or dietary supplement for management of human placental choriocarcinomas.",
keywords = "apoptosis, choriocarcinoma, ER stress, ROS, silibinin",
author = "Jiyeon Ham and Whasun Lim and Bazer, {Fuller W.} and Gwonhwa Song",
year = "2018",
month = "2",
day = "1",
doi = "10.1002/jcp.26069",
language = "English",
volume = "233",
pages = "1638--1649",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells

AU - Ham, Jiyeon

AU - Lim, Whasun

AU - Bazer, Fuller W.

AU - Song, Gwonhwa

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Silibinin is a flavonolignan extracted from seeds of milk thistles. Traditionally, it has been used as a therapeutic agent for liver disorders, and now it is well-known for its anti-cancer effects. However, studies on anti-cancer effects of silibinin on choriocarcinoma are very limited. Therefore, we performed proliferation and apoptosis assays to determine effects of silibinin on the viability of human choriocarcinoma (JAR and JEG3) cells. Our results showed that silibinin significantly inhibited proliferation and induced apoptosis in both JAR and JEG3 cells, and significantly increased reactive oxygen species (ROS) and lipid peroxidation. Moreover, silibinin disrupted mitochondrial function by inducing permeabilization of mitochondrial membrane potential and calcium ion efflux in JAR and JEG3 cells. Furthermore, silibinin-induced apoptosis in choriocarcinoma cells via AKT, mitogen-activated protein kinases (MAPK) and unfolded protein response (UPR) signal transduction. Collectively, our results suggest that silibinin is a novel therapeutic agent or dietary supplement for management of human placental choriocarcinomas.

AB - Silibinin is a flavonolignan extracted from seeds of milk thistles. Traditionally, it has been used as a therapeutic agent for liver disorders, and now it is well-known for its anti-cancer effects. However, studies on anti-cancer effects of silibinin on choriocarcinoma are very limited. Therefore, we performed proliferation and apoptosis assays to determine effects of silibinin on the viability of human choriocarcinoma (JAR and JEG3) cells. Our results showed that silibinin significantly inhibited proliferation and induced apoptosis in both JAR and JEG3 cells, and significantly increased reactive oxygen species (ROS) and lipid peroxidation. Moreover, silibinin disrupted mitochondrial function by inducing permeabilization of mitochondrial membrane potential and calcium ion efflux in JAR and JEG3 cells. Furthermore, silibinin-induced apoptosis in choriocarcinoma cells via AKT, mitogen-activated protein kinases (MAPK) and unfolded protein response (UPR) signal transduction. Collectively, our results suggest that silibinin is a novel therapeutic agent or dietary supplement for management of human placental choriocarcinomas.

KW - apoptosis

KW - choriocarcinoma

KW - ER stress

KW - ROS

KW - silibinin

UR - http://www.scopus.com/inward/record.url?scp=85032927593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032927593&partnerID=8YFLogxK

U2 - 10.1002/jcp.26069

DO - 10.1002/jcp.26069

M3 - Article

C2 - 28657208

AN - SCOPUS:85032927593

VL - 233

SP - 1638

EP - 1649

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 2

ER -